Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Are Electronic Cigarette Users at Increased Risk for Cardiovascular Disease?

Are Electronic Cigarette Users at Increased Risk for Cardiovascular Disease? Editorial Opinion and paclitaxel stents for coronary revascularization eligible patients: a secondary analysis of a fracture: an independent bench comparison of six in daily practice). JACC Cardiovasc Interv. 2015;8(9): randomized clinical trial [published online January contemporary designs using a repetitive bend test. 1157-1165. 18, 2017]. JAMA Cardiol. doi:10.1001/jamacardio EuroIntervention. 2015;10(12):1449-1455. .2016.5190 8. Iqbal J, Serruys PW, Silber S, et al. Comparison of 12. Piccolo R, Stefanini GG, Franzone A, et al. Safety zotarolimus- and everolimus-eluting coronary 10. von Birgelen C, Basalus MW, Tandjung K, et al. and efficacy of resolute zotarolimus-eluting stents stents: final 5-year report of the RESOLUTE A randomized controlled trial in second-generation compared with everolimus-eluting stents: all-comers trial. Circ Cardiovasc Interv. 2015;8(6): zotarolimus-eluting Resolute stents versus a meta-analysis. Circ Cardiovasc Interv. 2015;8(4): e002230. everolimus-eluting Xience V stents in real-world e002223. patients: the TWENTE trial. J Am Coll Cardiol. 2012; 9. von Birgelen C, van der Heijden LC, Basalus 59(15):1350-1361. MWZ, et al. Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in 11. Ormiston JA, Webber B, Ubod B, White J, randomized trial participants and nonenrolled Webster MW. Coronary stent durability and Are Electronic Cigarette Users at Increased Risk for Cardiovascular Disease? Aruni Bhatnagar, PhD The http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Are Electronic Cigarette Users at Increased Risk for Cardiovascular Disease?

JAMA Cardiology , Volume 2 (3) – Mar 1, 2017

Loading next page...
 
/lp/american-medical-association/are-electronic-cigarette-users-at-increased-risk-for-cardiovascular-htTeoKz7YD

References (13)

Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2016.5550
Publisher site
See Article on Publisher Site

Abstract

Editorial Opinion and paclitaxel stents for coronary revascularization eligible patients: a secondary analysis of a fracture: an independent bench comparison of six in daily practice). JACC Cardiovasc Interv. 2015;8(9): randomized clinical trial [published online January contemporary designs using a repetitive bend test. 1157-1165. 18, 2017]. JAMA Cardiol. doi:10.1001/jamacardio EuroIntervention. 2015;10(12):1449-1455. .2016.5190 8. Iqbal J, Serruys PW, Silber S, et al. Comparison of 12. Piccolo R, Stefanini GG, Franzone A, et al. Safety zotarolimus- and everolimus-eluting coronary 10. von Birgelen C, Basalus MW, Tandjung K, et al. and efficacy of resolute zotarolimus-eluting stents stents: final 5-year report of the RESOLUTE A randomized controlled trial in second-generation compared with everolimus-eluting stents: all-comers trial. Circ Cardiovasc Interv. 2015;8(6): zotarolimus-eluting Resolute stents versus a meta-analysis. Circ Cardiovasc Interv. 2015;8(4): e002230. everolimus-eluting Xience V stents in real-world e002223. patients: the TWENTE trial. J Am Coll Cardiol. 2012; 9. von Birgelen C, van der Heijden LC, Basalus 59(15):1350-1361. MWZ, et al. Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in 11. Ormiston JA, Webber B, Ubod B, White J, randomized trial participants and nonenrolled Webster MW. Coronary stent durability and Are Electronic Cigarette Users at Increased Risk for Cardiovascular Disease? Aruni Bhatnagar, PhD The

Journal

JAMA CardiologyAmerican Medical Association

Published: Mar 1, 2017

There are no references for this article.